ScienceDex / Researcher record
Wei Li
- University of Tennessee Health Science Center · Pharmacology (NIH department code)
- Seak Therapeutics, Llc (no department on record)
From the FY2025 NIH awards this investigator leads as contact PI. The department is the award's.
FY2025 NIH rank #3,230
- R01 Holder
- Early Career
- Diverse Portfolio
NIH Funding · FY2025
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
Linked awards ($M)Award-linked rank
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2024 | $1,468,906 | 3 | #8,927 |
| 2025 | $3,098,026 | 6 | #3,230 |
| 2026 | $1,959,963 | 3 | #10,674 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20243 records
- FY2025 · selected6 records
- FY20263 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 8363577Search this ID in NIH RePORTER
- ORCID iD
- https://orcid.org/0000-0002-9522-4474Verified identifier for this researcher
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
FY2026 award categories
- Pharmacology
FY2025 award records by amount
NIH award records listing Wei Li as a PI. Multi-PI records show the full award amount for context.
- 4R01AG072703-02R01Co-investigatorValidation of a novel tau clearance mechanism.University of Tennessee Health Science Center · Pharmacology (NIH department code)$688.3Kaward amount
- 1R01CA295996-01A1R01Contact PITargeted MDM2 degradation for improved treatment for triple-negative breast cancerUniversity of Tennessee Health Science Center · Pharmacology (NIH department code)$658.6Kaward amount
- 5R01CA276152-03R01Contact PITargeting brain and bone metastases in metastatic breast cancer for improved patient survivalUniversity of Tennessee Health Science Center · Pharmacology (NIH department code)$614.9Kaward amount
- 1R41CA310186-01R41Contact PIDevelopment of a potent and highly brain-penetrable antimitotic agent SEAK193 to treat breast cancer brain metastasis$400Kaward amount
- 5R01CA148706-15R01Contact PITargeting the colchicine binding site in tubulin for cancer therapyUniversity of Tennessee Health Science Center · Pharmacology (NIH department code)$389.8Kaward amount
- 4R33NS124923-03R33Co-investigatorTargeting TRPC3 Channels for Epileptic SeizuresUniversity of Tennessee Health Science Center · Pharmacology (NIH department code)$346.5Kaward amount
Award organizations
Organizations that administered FY2025 awards listing Wei Li as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardUniversity of Tennessee Health Science Center
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #8927
- 2025$2M Cumulative Funding
- 2025Entered Top 25% NationallyRanked #3230
- 2025Multi-Institutional ResearchAwards at 2 institutions
- 2025R01 Grant Holder
- 2026$5M Cumulative Funding
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Wei Li.
Tiffany Nicole Seagroves
University of Tennessee Health Science Center
3
shared awards
Duane D Miller
University of Tennessee Health Science Center
2
shared awards
Francesca-Fang Liao
University of Tennessee Health Science Center
2
shared awards
Kiran Bhaskar
University of Tennessee Health Science Center
2
shared awards
Wei Wang
University of Tennessee Health Science Center
2
shared awards
Jianxiong Jiang
University of Tennessee Health Science Center
1
shared award
Muxiang Zhou
University of Tennessee Health Science Center
1
shared award